Denali Therapeutics
DNLI
#3991
Rank
A$4.35 B
Marketcap
A$29.70
Share price
-1.35%
Change (1 day)
-23.85%
Change (1 year)

Denali Therapeutics (DNLI) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.59 Billion

According to Denali Therapeutics 's latest financial reports the company's total assets are A$1.59 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Denali Therapeutics - Total assets on balance sheet (from 2016 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$2.20 B30.44%
2023-12-31A$1.69 B-21.07%
2022-12-31A$2.14 B10.79%
2021-12-31A$1.93 B-7.17%
2020-12-31A$2.08 B164.04%
2019-12-31A$0.79 B-15.91%
2018-12-31A$0.93 B50.73%
2017-12-31A$0.62 B65.79%
2016-12-31A$0.37 B646.8%
2015-12-31A$50.35 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novocure
NVCR
A$2.05 B 28.95% Jersey
Novavax
NVAX
A$1.77 B 11.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
A$22.09 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$0.30 B-80.84%๐Ÿ‡ฌ๐Ÿ‡ง UK